BeyondSpring’s Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for Chemotherapy-Induced Neutropenia Presented at ASH 2019 Annual Meeting

by NASDAQ Market News December 10, 2019

NASDAQ Market News
Click here to email author

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

Navigen Announces FDA Clearance of its IND Application to Initiate First-in-Human Studies for CPT31, a Novel, D-peptide HIV Entry Inhibitor

Ads